{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:00:38Z","timestamp":1790103638783,"version":"4.0.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Gallbladder, biliary, and pancreatic disorders are nonneoplastic diseases marked by inflammation, epithelial injury, and fibrosis. Cathepsins are lysosomal proteases involved in inflammatory activation, immune regulation, extracellular matrix turnover, and pancreatic enzyme activation. Observational links between dysregulated cathepsins and hepatopancreatobiliary pathology could reflect confounding or reverse causation. This study used Mendelian randomization (MR) to assess whether circulating cathepsins causally influence gallbladder, biliary, and pancreatic diseases. We conducted a 2-sample MR analysis using genetic variants associated with circulating cathepsin levels from the INTERVAL genome-wide association studies (3301 European participants). Summary statistics for cholecystitis, cholelithiasis, primary biliary cholangitis (PBC), primary sclerosing cholangitis, acute pancreatitis, and chronic pancreatitis were extracted from European-ancestry genome-wide association studies consortia. Instrumental variables were selected at\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20055\u2005\u00d7\u200510\n                      <jats:sup>\u22126<\/jats:sup>\n                      with linkage disequilibrium\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005&lt;\u20050.001 to maximize instrument availability while retaining independence. The inverse-variance weighted estimator was the primary model, complemented by weighted median, MR-Egger, and mode-based methods. Instrument strength, pleiotropy, and heterogeneity were evaluated via\n                      <jats:italic toggle=\"yes\">F<\/jats:italic>\n                      statistics, MR-Egger intercept, MR Pleiotropy RESidual Sum and Outlier, and Cochran\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      . Benjamini\u2013Hochberg false discovery rate (FDR) correction accounted for multiple testing, and sensitivity analyses included leave-one-out tests and PhenoScanner filtering. Two cathepsin B associations remained significant after FDR correction. Higher genetically predicted cathepsin B was linked to lower PBC risk (odds ratio [OR]\u2005=\u20050.784; 95% confidence interval [CI]: 0.664\u20130.925;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.004; FDR\u2005=\u20050.022) and higher cholecystitis risk (OR\u2005=\u20051.080; 95% CI: 1.022\u20131.141;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.006; FDR\u2005=\u20050.018). Other nominal associations did not survive correction and should be interpreted cautiously: cathepsin O with cholelithiasis (OR\u2005=\u20051.001; 95% CI: 1.000\u20131.003;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.033; FDR\u2005=\u20050.199), cathepsin L2 with acute pancreatitis (OR\u2005=\u20051.156; 95% CI: 1.008\u20131.327;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.038; FDR\u2005=\u20050.227), and cathepsin H with chronic pancreatitis (OR\u2005=\u20050.922; 95% CI: 0.853\u20130.997;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.043; FDR\u2005=\u20050.255). No heterogeneity, horizontal pleiotropy, or reverse causation was detected. Genetically predicted cathepsin B appears protective for PBC but increases cholecystitis risk, supporting distinct causal roles among circulating cathepsins in hepatopancreatobiliary diseases. Associations involving cathepsin O, L2, and H were nominal, warranting cautious interpretation, replication, and further functional studies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050809","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:02:15Z","timestamp":1789750935000},"page":"e50809","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal effects of circulating cathepsins on cholecystitis, cholelithiasis, primary biliary cholangitis, primary sclerosing cholangitis, acute pancreatitis, and chronic pancreatitis"],"prefix":"10.1097","volume":"105","author":[{"given":"Tian","family":"Zou","sequence":"first","affiliation":[{"name":"Department of Nephrology, Yanbian University Hospital, Yanji, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehang","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yanbian University Hospital, Yanji, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xuan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yanbian University Hospital, Yanji, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yanbian University Hospital, Yanji, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3466-5922","authenticated-orcid":false,"given":"Yuji","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yanbian University Hospital, Yanji, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12876-025-03592-w","article-title":"Age-period-cohort analysis of gallbladder and biliary diseases epidemiological trends from 1990 to 2021 and forecasts for 2035: a systematic analysis from the global burden of disease study 2021.","volume":"25","author":"He","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S2468-1253(16)30004-8","article-title":"Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies.","volume":"1","author":"Xiao","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20260922","doi-asserted-by":"crossref","first-page":"111754","DOI":"10.1016\/j.biopha.2021.111754","article-title":"The pathogenesis, models and therapeutic advances of primary biliary cholangitis.","volume":"140","author":"Li","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbapap.2011.10.002","article-title":"Cysteine cathepsins: from structure, function and regulation to new frontiers.","volume":"1824","author":"Turk","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R5-20260922","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3390\/cells9071679","article-title":"The ins and outs of cathepsins: physiological function and role in disease management.","volume":"9","author":"Yadati","year":"2020","journal-title":"Cells"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0952-7915(99)00058-8","article-title":"Cathepsins and compartmentalization in antigen presentation.","volume":"12","author":"Riese","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"R7-20260922","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1016\/j.bbagen.2014.03.017","article-title":"Cysteine cathepsins and extracellular matrix degradation.","volume":"1840","author":"Fonovi\u0107","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"R8-20260922","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yexcr.2017.11.015","article-title":"Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome.","volume":"362","author":"Bai","year":"2018","journal-title":"Exp Cell Res"},{"key":"R9-20260922","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-5793(94)01349-6","article-title":"Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2.","volume":"357","author":"Shi","year":"1995","journal-title":"FEBS Lett"},{"key":"R10-20260922","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jclinpath-2019-205939","article-title":"Prognostic significance of cathepsin V (CTSV\/CTSL2) in breast ductal carcinoma in situ.","volume":"73","author":"Toss","year":"2020","journal-title":"J Clin Pathol"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1471-4159.2012.07788.x","article-title":"Cathepsin H functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin peptide neurotransmitters.","volume":"122","author":"Lu","year":"2012","journal-title":"J Neurochem"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R13-20260922","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1017\/S0033291724000321","article-title":"Mendelian randomization: causal inference leveraging genetic data.","volume":"54","author":"Chen","year":"2024","journal-title":"Psychol Med"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants.","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"1365138","DOI":"10.3389\/fonc.2024.1365138","article-title":"The causal relationship between cathepsins and digestive system tumors: a Mendelian randomization study.","volume":"14","author":"Huang","year":"2024","journal-title":"Front Oncol"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"1436407","DOI":"10.3389\/fgene.2024.1436407","article-title":"Bidirectional two-sample Mendelian randomization analysis investigates causal associations between cathepsins and inflammatory bowel disease.","volume":"15","author":"Wang","year":"2024","journal-title":"Front Genet"},{"key":"R18-20260922","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes.","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"R19-20260922","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s43587-021-00051-5","article-title":"Common genetic associations between age-related diseases.","volume":"1","author":"D\u00f6nerta\u015f","year":"2021","journal-title":"Nat Aging"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1038\/ncomms9019","article-title":"International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.","volume":"6","author":"Cordell","year":"2015","journal-title":"Nat Commun"},{"key":"R21-20260922","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"key":"R22-20260922","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.","volume":"45","author":"Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R23-20260922","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R24-20260922","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R25-20260922","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R26-20260922","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/j.gastro.2013.01.068","article-title":"The epidemiology of pancreatitis and pancreatic cancer.","volume":"144","author":"Yadav","year":"2013","journal-title":"Gastroenterology"},{"key":"R27-20260922","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.trsl.2020.04.011","article-title":"Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis.","volume":"222","author":"Fang","year":"2020","journal-title":"Transl Res"},{"key":"R28-20260922","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1172\/JCI9411","article-title":"Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis.","volume":"106","author":"Halangk","year":"2000","journal-title":"J Clin Invest"},{"key":"R29-20260922","doi-asserted-by":"crossref","first-page":"G894","DOI":"10.1152\/ajpgi.00073.2012","article-title":"Active cathepsins B, L, and S in murine and human pancreatitis.","volume":"303","author":"Lyo","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R30-20260922","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jhep.2021.06.031","article-title":"The multifaceted role of cathepsins in liver disease.","volume":"75","author":"Ruiz-Bl\u00e1zquez","year":"2021","journal-title":"J Hepatol"},{"key":"R31-20260922","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/cells8030264","article-title":"Cysteine cathepsins and their extracellular roles: shaping the microenvironment.","volume":"8","author":"Vidak","year":"2019","journal-title":"Cells"},{"key":"R32-20260922","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrc4027","article-title":"Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.","volume":"15","author":"Olson","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"Pt A","key":"R33-20260922","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mito.2014.06.006","article-title":"Lysosomal membrane permeabilization in cell death: concepts and challenges.","volume":"19","author":"Repnik","year":"2014","journal-title":"Mitochondrion"},{"key":"R34-20260922","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/j.gastro.2023.05.039","article-title":"Macrophage-derived cathepsin s remodels the extracellular matrix to promote liver fibrogenesis.","volume":"165","author":"Zuo","year":"2023","journal-title":"Gastroenterology"},{"key":"R35-20260922","doi-asserted-by":"crossref","first-page":"107496","DOI":"10.1016\/j.intimp.2021.107496","article-title":"Cathepsin B aggravates acute pancreatitis by activating the NLRP3 inflammasome and promoting the caspase-1-induced pyroptosis.","volume":"94","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R36-20260922","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1038\/sj.onc.1207512","article-title":"Lysosomes in cell death.","volume":"23","author":"Guicciardi","year":"2004","journal-title":"Oncogene"},{"key":"R37-20260922","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1038\/ctg.2017.25","article-title":"Cathepsin L and B as potential markers for liver fibrosis: insights from patients and experimental models.","volume":"8","author":"Manchanda","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"R38-20260922","doi-asserted-by":"crossref","first-page":"453","DOI":"10.18097\/pbmc20216706453","article-title":"Tsisteinovye katepsiny: stroenie, fiziologicheskie funktsii i rol\u2019 v kantserogeneze (Cysteine cathepsins: structure, physiological functions and their role in carcinogenesis).","volume":"67","author":"Gureeva","year":"2021","journal-title":"Biomed Khim"},{"key":"R39-20260922","doi-asserted-by":"crossref","first-page":"105033","DOI":"10.4240\/wjgs.v17.i7.105033","article-title":"Association between hereditary spherocytosis and gallstone disease: pathophysiology, diagnosis, and management.","volume":"17","author":"Cong","year":"2025","journal-title":"World J Gastrointest Surg"},{"key":"R40-20260922","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/bi982175f","article-title":"Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization.","volume":"38","author":"Br\u00f6mme","year":"1999","journal-title":"Biochemistry"},{"key":"R41-20260922","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1172\/JCI42918","article-title":"Specialized roles for cysteine cathepsins in health and disease.","volume":"120","author":"Reiser","year":"2010","journal-title":"J Clin Invest"},{"key":"R42-20260922","doi-asserted-by":"crossref","first-page":"101086","DOI":"10.1016\/j.mam.2022.101086","article-title":"Cathepsin V: molecular characteristics and significance in health and disease.","volume":"88","author":"Lecaille","year":"2022","journal-title":"Mol Aspects Med"},{"key":"R43-20260922","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2009.10.048","article-title":"Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice.","volume":"138","author":"Wartmann","year":"2010","journal-title":"Gastroenterology"},{"key":"R44-20260922","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.gastro.2012.12.043","article-title":"Models of acute and chronic pancreatitis.","volume":"144","author":"Lerch","year":"2013","journal-title":"Gastroenterology"},{"key":"R45-20260922","doi-asserted-by":"crossref","first-page":"115585","DOI":"10.1016\/j.bcp.2023.115585","article-title":"Cathepsin H: molecular characteristics and clues to function and mechanism.","volume":"212","author":"Wang","year":"2023","journal-title":"Biochem Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:03:52Z","timestamp":1790100232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050809"}},"subtitle":["A Mendelian randomization study"],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":45,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050809","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2025-11-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}